Skip to main content
ROIV
NASDAQ Life Sciences

Roivant President & CIO Sells Over $34 Million in Shares

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$34.74
Mkt Cap
$24.98B
52W Low
$10.705
52W High
$34.83
52W Position info
225% above low
Off High info
at 52W high
Rel. Volume info
1.1× avg
Market data snapshot near publication time

ROIV has more than doubled off its 52-week low of $10.705.

Summary

Roivant Sciences' President and CIO, Mayukh Sukhatme, sold over $34 million worth of common shares in an open market transaction, following the exercise of stock options.


Key Events · Ownership and Investor Activity · ROIV

  • Insider Sale

    President and CIO Mayukh Sukhatme sold 1,000,000 shares for a total of $34,105,000 in open market transactions.

  • Option Exercise Preceding Sale

    The sale followed the exercise of 1,000,000 stock options at a cost of $3,850,000.

  • Key Executive Disposition Near Highs

    This significant open market sale by a top executive occurred while the stock is trading near its 52-week high, adding to a recent pattern of insider distribution.


Analysis · ROIV · Life Sciences

Mayukh Sukhatme, President and CIO, executed a significant sale of company stock, disposing of over $34 million in shares. This transaction, occurring near the company's 52-week high, represents a notable reduction in direct holdings by a key executive. While the sale followed an option exercise, the substantial open market disposition by a top insider can be interpreted as a lack of conviction at current price levels.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, ROIV was trading at $34.74 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $25B. The 52-week trading range was $10.71 to $34.83. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ROIV - Latest Insights

ROIV
Nov 09, 2026, 7:36 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $41.37
Real-time Price: $38.68 info
Change: -$2.69 (-7%) info
Market Cap: $28.008B info
ROIV
Nov 09, 2026, 7:17 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $41.00
Real-time Price: $38.68 info
Change: -$2.32 (-6%) info
Market Cap: $28.008B info
ROIV
Nov 09, 2026, 7:01 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $40.39
Real-time Price: $38.68 info
Change: -$1.71 (-4%) info
Market Cap: $28.008B info
ROIV
Oct 21, 2026, 7:05 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $36.20
Real-time Price: $38.68 info
Change: +$2.48 (+7%) info
Market Cap: $28.008B info
ROIV
Oct 21, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $36.60
Real-time Price: $38.68 info
Change: +$2.08 (+6%) info
Market Cap: $28.008B info